Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers

Fig. 2

Effect of ALK signaling on NHERF1 expression (a) The expression of NHERF1 during the time course of crizotinib treatment for 7 days in H3122 cells (Full-length blots/gels are presented in Suppl Figure 2). b A dose dependent autophosphorylation of ALK through heparin stimulation increased NHERF1 expression in H3122 cells. (Full-length blots/gels are presented in Suppl Figure 2)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us